Europe
Scientists have revealed close-up details of a vital molecule involved in the mix and match of genetic information within cells – opening up the potential to target proteins of this family to combat cancer’s diversity and evolution.
Lundbeck announced the acquisition aimed at eptinezumab, Alder’s investigational monoclonal antibody (mAb) for migraine prevention targeting the calcitonin gene-related peptide that has been submitted to the U.S. Food and Drug Administration for potential approval.
Medical device maker Medtronic and Novo Nordisk have entered a collaboration pact to develop ways of integrating insulin dosing management data from future Novo Nordisk smart insulin pens into Continuous Glucose Monitoring devices from Medtronic.
NOXXON Pharma N.V. announced the start of recruitment of newly diagnosed brain cancer patients in a Phase 1/2 clinical trial combining the CXCL12 inhibitor NOX-A12 with radiotherapy.
An international group of researchers working with Erasmus University Medical Center in the Netherlands determined that SkinVision – the first CE-marked skin cancer application based on extensive clinical trials – has a sensitivity of 95.1% in detecting the most common forms of skin cancer.
fast-progressing multiple myeloma patients of 65 years and older that won’t undergo a stem cell transplantation live 42 months longer when treated with the option of an MPR-R regime.
Biocrates Life Sciences AG, one of the world’s leading biotech companies in the field of metabolomics, is strategically realigning.
Company’s multiple sclerosis Imotope™ shows promising preclinical efficacy and histology results while eliciting immune responses supporting the proposed mode of action and providing proof of concept
VAXIMM AG announced that the Company will participate in several events around the globe in the coming months.
Nucala is the only targeted biologic to be approved for the condition in the six to 11-year age group in the United States, the company said.
PRESS RELEASES